FK-506 and haemolytic uraemic syndrome.
Brown
Z
Z
Neild
G H
GH
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004341:Drug Evaluation; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016559:Tacrolimus
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus